BioChemics Inc., of Danvers, Mass., was issued U.S. Patent No...Mesoblast Ltd., of Melbourne, Australia, was issued U.S. Patent No...MiMedx Group Inc., of Kennesaw, Ga., was issued U.S. Patent No

Addex Therapeutics SA, of Geneva, was issued U.S. Patent No...Anergis, of Epalinges, Switzerland, was issued U.S. Patent No...NeoStem Inc., of New York, was issued U.S. Patent No

Immunomedics Inc., of Morris Plains, N.J., was issued U.S. Patent No...MonoSol Rx LLC, of Warren, N.J., has acquired U.S. Patent No...RedHill Biopharma Ltd., of Tel-Aviv, Israel, was issued U.S. Patent No

Curis Inc., of Lexington, Mass., was issued U.S. Patent No...MiMedx Group Inc., of Kennesaw, Ga., was issued U.S. Patent No...Sequenom Inc., of San Diego, was issued U.S. Patent No

AcelRx Pharmaceuticals Inc., of Redwood City, Calif., received U.S. Patent No...Coronado Biosciences Inc., of Burlington, Mass., received U.S. Patent No...Histogen Inc., of San Diego, was issued U.S. Patent No

AcelRx Pharmaceuticals Inc., of Redwood City, Calif., was issued U.S. Patent No...Aeterna Zentaris Inc., of Quebec City, was issued U.S. Patent No...Ziopharm Oncology Inc., of New York, was issued U.S. Patent No

Galectin Therapeutics Inc., of Newton, Mass., was issued U.S. Patent No...GeNO LLC, of Cocoa, Fla., was issued U.S. Patent No...Trovagene Inc., of San Diego, was issued U.S. Patent No

Depomed Inc., of Menlo Park, Calif., received U.S. Patent No...pSivida Corp., of Watertown, Mass., received U.S. Patent No...Transgenomic Inc., of Omaha, Neb., received U.S. Patent No

The patent also is related to treating radiation-induced mucositis, a side effect of radiation treatment for cancer...The patent is related to a method for extending the company's BH3 profiling technology, licensed from Dana Farber Cancer Institute

Athersys Inc., of Cleveland, was issued Patent No...BioLineRx Ltd., of Jerusalem, received a patent term adjustment for its patent on the composition of BCM (BL-1040), a device for prevention of cardiac remodeling following acute myocardial infarction...The patent is now extended through April 30, 2029

MAP Pharmaceuticals Inc., of Mountain View, Calif., received U.S. Patent No...Nuclea Biotechnologies Inc., of Pittsfield, Mass., received U.S. Patent No...XenoPort Inc., of Santa Clara, Calif., received U.S. Patent No

Ariad Pharmaceuticals Inc., of Cambridge, Mass., received U.S. Patent No...Athersys Inc., of Cleveland, received U.S. Patent No...iBio Inc., of Newark, Del., received U.S. Patent No

ARCA Biopharma Inc., of Broomfield, Colo., received U.S. Patent No...Pharmacyclics Inc., of Sunnyvale, Calif., received U.S. Patent No...Xencor Inc., of Monrovia, Calif., received U.S. Patent No

Aegis Therapeutics LLC, of San Diego, received U.S. Patent No...The firm also received U.S. Patent No...Amorcyte Inc., of New York, received U.S. Patent No

Resverlogix Corp., of Calgary, Alberta, received U.S. Patent No...Revotar Biopharmaceuticals AG, of Berlin, received U.S. Patent No...Virxsys Corp., of Gaithersburg, Md., received U.S. Patent No

Nutra Pharma Corp., of Coral Springs, Fla., received U.S. Patent No...Prosensa NV, of Leiden, the Netherlands, was granted U.S. Patent No

BioSante Pharmaceuticals Inc., of Lincolnshire, Ill., received U.S. Patent No...Fate Therapeutics Inc., of San Diego, was granted U.S. Patent No...Immunomedics Inc., of Morris Plains, N.J., received U.S. Patent No

Alethia Biotherapeutics Inc., of Montreal, received U.S. Patent No...Amgen Inc., of Thousand Oaks, Calif., was issued U.S. Patent No...Asmacure Ltee, of Quebec City, received U.S. Patent No

Stem Cell Therapeutics Corp., of Calgary, Alberta, said it received U.S. Patent No...Trophos SA, of Marseille, France, was granted U.S. Patent No...Vermillion Inc., of Austin, Texas, received U.S. Patent No